These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32656345)

  • 1. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.
    DeVuono MV; Parker LA
    Cannabis Cannabinoid Res; 2020 Jun; 5(2):132-144. PubMed ID: 32656345
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
    Richards JR; Lapoint JM; Burillo-Putze G
    Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation.
    Russo EB; Spooner C; May L; Leslie R; Whiteley VL
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):336-344. PubMed ID: 34227878
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
    Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
    Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis hyperemesis syndrome: an update on the pathophysiology and management.
    Perisetti A; Gajendran M; Dasari CS; Bansal P; Aziz M; Inamdar S; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):571-578. PubMed ID: 33162734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
    Wallace EA; Andrews SE; Garmany CL; Jelley MJ
    South Med J; 2011 Sep; 104(9):659-64. PubMed ID: 21886087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.
    Perisetti A; Goyal H
    Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):1-8. PubMed ID: 33208685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid Hyperemesis.
    Pergolizzi JV; LeQuang JA; Bisney JF
    Med Cannabis Cannabinoids; 2019 Jan; 1(2):73-95. PubMed ID: 34676325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid hyperemesis syndrome: a review of the literature.
    Deceuninck E; Jacques D
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
    Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
    Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
    Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
    Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
    Hernandez JM; Paty J; Price IM
    CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol Interferes with Establishment of Δ
    DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
    [No Abstract]   [Full Text] [Related]  

  • 20. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.